30 /100
MEDIUM RISK
Score updated May 30, 2026

CYTK — Cytokinetics, Incorporated Dilution Risk Tracker

Track CYTK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CYTK — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
🔁 Convertible Conversion 15%
• Convertible debt present: 7.0% potential dilution
🔔 Track CYTK — Get forecast alerts →

💹 Market Data

Market Cap$10.42B
Shares Outstanding135.77M
Float123.91M
Cash$818.55M
Debt$1.44B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.4% shares (2025Q4 vs prior)
436 institutional holders · 161.64M shares
#1 T. Rowe Price Investment Management, Inc. 27.11M shares
#2 BlackRock, Inc. 16.40M shares
#3 FMR LLC 12.81M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest16.46M
Days to Cover3.4
% of Float13.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CYTK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CYTK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CYTK
📊 CYTK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CYTK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.